Scrip
GSK's malaria vaccine sails towards uncharted territory
05 November 2009
Elizabeth Sukkar
Please Login to read the full article.
05 November 2009
Elizabeth Sukkar
elizabeth.sukkar@informa.com
GlaxoSmithKline will enter unknown regulatory waters when it eventually comes to seek approval of its paediatric malaria vaccine, RTS,S, the most advanced in development for this disease. The parasite kills more than 800,000 people every year, the majority of whom are children under the age of five...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US panel endorses WHO's antimalarial artesunate suppository for young children
- Counterfeiters beware: WHO shows poor countries how to procure antimalarials
- GSK is top contender for $1.5 billion pneumococcal vaccine scheme
- One dose of Sanofi Pasteur's H1N1 vaccine fails to provide children with seroprotection
COMMENT
Other Informa Comment
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
